Evaxion A/S
Evaxion A/S is a Healthcare company operating in Biotechnology with a $28.5M market cap.
Most recent earnings call: Q1 FY26 on May 7, 2026.
14 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks EVAX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 60% of the time
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for EVAX.
$ curl https://api.spokenalpha.com/v1/companies/EVAXFAQ
Spoken Alpha indexes EVAX's earnings call transcripts at https://spokenalpha.com/companies/EVAX. Each call links to attributed speakers and parsed analyst Q&A. Evaxion A/S's own investor relations page is at https://evaxion.ai/investors/.
Evaxion A/S (EVAX) held its most recent earnings call on 2026-05-07, covering fiscal Q1 2026.
Evaxion A/S (EVAX) operates in the Healthcare sector (Biotechnology industry).
When a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.54 | $1.21 | +27.0% | -4.1% | -6.8% |
| Q4 FY2026 | $1.33 | $1.06 | +25.1% | -4.3% | -1.5% |
| Q3 FY2026 | $1.48 | $1.12 | +32.1% | +0.7% | +1.9% |
| Q2 FY2026 | $1.50 | $1.22 | +23.3% | -4.9% | -3.5% |
| Q1 FY2025 | $1.42 | $1.15 | +23.8% | -2.6% | -1.9% |
| Q4 FY2025 |
| $1.56 |
| $1.17 |
| +33.4% |
| -1.5% |
| -0.2% |
| Q3 FY2025 | $1.58 | $1.19 | +32.7% | +4.8% | +6.1% |
| Q2 FY2025 | $1.77 | $1.33 | +33.4% | +4.8% | +3.8% |
| Q1 FY2024 | $1.51 | $1.17 | +29.0% | +6.1% | +8.9% |
| Q4 FY2024 | $1.54 | $1.19 | +29.1% | -5.8% | -8.1% |